Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · IEX Real-Time Price · USD
0.441
-0.040 (-8.29%)
Apr 19, 2024, 3:57 PM EDT - Market closed

Catheter Precision Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Cash & Equivalents
3.5715.8615.0523.9114.5864.328.243.92
Short-Term Investments
000015.99000
Cash & Cash Equivalents
3.5715.8615.0523.9130.5864.328.243.92
Cash Growth
-77.52%5.41%-37.07%-21.82%-52.46%680.81%110.07%-
Receivables
0.1400.020.020.791.320.520.39
Inventory
0.0400.990.882.782.11.20.87
Other Current Assets
0.420.981.042.811.861.50.090.12
Total Current Assets
4.1616.8417.0927.623669.2310.045.31
Property, Plant & Equipment
0.2503.925.017.894.761.160.51
Goodwill and Intangibles
26.320000000
Other Long-Term Assets
0.0100.040.810.20.050.070.03
Total Long-Term Assets
26.5803.965.828.084.81.230.53
Total Assets
30.7416.8421.0433.4444.0874.0411.275.84
Accounts Payable
7.440.090.990.471.531.130.430.47
Deferred Revenue
00003.262.492.492.58
Current Debt
0.2800.281.040.610.290.040.04
Other Current Liabilities
-5.247.484.126.251.412.04-0.33-0.39
Total Current Liabilities
2.477.585.397.766.815.952.632.71
Long-Term Debt
0.101.983.842.890.560.020.07
Other Long-Term Liabilities
6.97000.691.230.8216.233.45
Total Long-Term Liabilities
7.0701.984.534.121.3816.253.51
Total Liabilities
9.547.587.3712.2910.937.3318.886.22
Total Debt
0.3702.264.893.50.850.060.11
Debt Growth
---53.65%39.73%311.29%1249.21%-41.12%-
Retained Earnings
-275.71-205.14-178.27-153.2-117.16-60.22-29.39-11.62
Comprehensive Income
00000.03000
Shareholders' Equity
21.199.2613.6721.1533.1566.71-7.62-0.38
Net Cash / Debt
3.1915.8612.7819.0227.0863.478.173.81
Net Cash / Debt Growth
-79.87%24.08%-32.81%-29.76%-57.33%676.43%114.32%-
Net Cash Per Share
0.5815.34126.54559.772574.248594.931354.21685.85
Working Capital
1.699.2611.719.8629.1963.287.412.6
Book Value Per Share
3.868.96135.38622.343151.149033.72-1261.60-68.33
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).